A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid

被引:56
作者
Arcenas, RC
Uhl, JR
Buckwalter, SP
Limper, AH
Crino, D
Roberts, GD
Wengenack, NL [1 ]
机构
[1] Mayo Clin, Coll Med, Div Clin Microbiol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA
关键词
LightCycler; Pneumocystis; PCR;
D O I
10.1016/j.diagmicrobio.2005.08.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Pneumocystis jiroveci is an important cause of pneumonia in immunocompromised individuals. This organism cannot be cultured, and therefore, diagnosis relies on microscopic identification of the organism using stains or antibodies. Although simple, these tests are insensitive and require expertise for accurate interpretation. We developed a real-time polymerase chain reaction (PCR) assay that provides sensitive and objective detection of Pneumocystis from bronchoalveolar lavage fluid. Primers and fluorescence resonance energy transfer probes were developed that target the cdc2 gene of P jiroveci. Assay sensitivity is 6 copies of target per microliter of sample. No cross-reactivity occurs with other pathogens, and the PCR assay has a 21% increase in clinical sensitivity as compared with Calcofluor white staining. The real-time PCR assay provides a sensitive, rapid, and objective method for the detection of Pneumocystis from bronchoalveolar lavage fluid. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 39 条
[11]   Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples [J].
Helweg-Larsen, J ;
Jensen, JS ;
Benfield, T ;
Svendsen, UG ;
Lundgren, JD ;
Lundgren, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) :2068-2072
[12]  
Kaiser K, 1999, J EUKARYOT MICROBIOL, V46, p130S
[13]   Evidence for cdc2 gene in Pneumocystis carinii hominis and its implication for culture [J].
Kaiser, K ;
Rabodonirina, M ;
Mayençon, M ;
Picot, S .
AIDS, 1999, 13 (03) :419-420
[14]   Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy [J].
Kaplan, JE ;
Hanson, D ;
Dworkin, MS ;
Frederick, T ;
Bertolli, J ;
Lindegren, ML ;
Holmberg, S ;
Jones, JL .
CLINICAL INFECTIOUS DISEASES, 2000, 30 :S5-S14
[15]   Diagnosis of Pneumocystis carinii pneumonia:: Immunofluorescence staining, simple PCR or nPCR [J].
Khan, MA ;
Farrag, N ;
Butcher, P .
JOURNAL OF INFECTION, 1999, 39 (01) :77-80
[16]   New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia [J].
Kovacs, JA ;
Gill, VJ ;
Meshnick, S ;
Masur, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19) :2450-2460
[17]   Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia [J].
Larsen, HH ;
Masur, H ;
Kovacs, JA ;
Gill, VJ ;
Silcott, VA ;
Kogulan, P ;
Maenza, J ;
Smith, M ;
Lucey, DR ;
Fischer, SH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (02) :490-494
[18]   Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp carinii [J].
Larsen, HH ;
Kovacs, JA ;
Stock, F ;
Vestereng, VH ;
Lundgren, B ;
Fischer, SH ;
Gill, VJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (08) :2989-2993
[19]   COMPARISON OF 6 DIFFERENT PCR METHODS FOR DETECTION OF PNEUMOCYSTIS-CARINII [J].
LU, JJ ;
CHEN, CH ;
BARTLETT, MS ;
SMITH, JW ;
LEE, CH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (10) :2785-2788
[20]   Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy:: a prospective study [J].
Maskell, NA ;
Waine, DJ ;
Lindley, A ;
Pepperell, JCT ;
Wakefield, AE ;
Miller, RF ;
Davies, RJO .
THORAX, 2003, 58 (07) :594-597